NO2714888T3 - - Google Patents
Info
- Publication number
- NO2714888T3 NO2714888T3 NO12727897A NO12727897A NO2714888T3 NO 2714888 T3 NO2714888 T3 NO 2714888T3 NO 12727897 A NO12727897 A NO 12727897A NO 12727897 A NO12727897 A NO 12727897A NO 2714888 T3 NO2714888 T3 NO 2714888T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Marine Sciences & Fisheries (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/114,429 US8778878B2 (en) | 2007-01-29 | 2011-05-24 | Use of ferritin to treat iron disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2714888T3 true NO2714888T3 (pl) | 2018-03-24 |
Family
ID=46317426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO12727897A NO2714888T3 (pl) | 2011-05-24 | 2012-05-24 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8778878B2 (pl) |
| EP (1) | EP2714888B1 (pl) |
| JP (1) | JP2014516535A (pl) |
| CN (1) | CN103635570A (pl) |
| AU (1) | AU2012260682B2 (pl) |
| BR (1) | BR112013029769B1 (pl) |
| CA (1) | CA2874042C (pl) |
| DK (1) | DK2714888T3 (pl) |
| ES (1) | ES2659185T3 (pl) |
| NO (1) | NO2714888T3 (pl) |
| PL (1) | PL2714888T3 (pl) |
| WO (1) | WO2012160333A2 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10249552A1 (de) | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
| DK1973549T3 (en) | 2006-01-06 | 2016-11-21 | Vifor (International) Ag | Methods and compositions for administration of the iron |
| US8778878B2 (en) * | 2007-01-29 | 2014-07-15 | Chyna, LLC | Use of ferritin to treat iron disorders |
| US20170273906A1 (en) * | 2014-08-21 | 2017-09-28 | Ramot At Tel-Aviv University Ltd. | Targeted liposomes encapsulating iron complexes and their uses |
| KR101811050B1 (ko) * | 2015-09-02 | 2017-12-21 | 경북대학교 산학협력단 | 항염증성 폴리펩티드와 페리틴 모노머 단편이 접합된 융합폴리펩티드 및 이를 유효성분으로 포함하는 염증성 질환 예방 및 치료용 약학적 조성물 |
| CN108503704A (zh) | 2017-02-27 | 2018-09-07 | 昆山新蕴达生物科技有限公司 | 穿越血脑屏障的纳米药物载体 |
| US20210220396A1 (en) * | 2018-06-04 | 2021-07-22 | Sidero Bioscience, Llc | Compositions and methods for improvement of iron metabolism and gut microbiome health |
| WO2020239809A1 (en) * | 2019-05-28 | 2020-12-03 | Previpharma Consulting Gmbh | Method for preparing iron-depleted ferritin and use thereof |
| CN110759986B (zh) * | 2019-10-18 | 2023-01-31 | 大连工业大学 | 一种可逆自组装蛋白的高效制备方法 |
| WO2022246088A1 (en) * | 2021-05-19 | 2022-11-24 | Sidero Bioscience, Llc | Ferritin composition tolerability |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100419530B1 (ko) * | 2000-11-15 | 2004-02-19 | 주식회사 알엔에이 | 재조합 메탄올 자화 효모를 이용한 인간 페리틴의 대량생산 방법 |
| KR100545981B1 (ko) * | 2003-04-08 | 2006-01-25 | 전북대학교산학협력단 | 이종중합형 패리틴 생산방법 |
| FR2898132B1 (fr) * | 2006-03-01 | 2012-09-28 | Mane Fils V | Systeme d'expression d'un gene d'interet chez la levure |
| US8778878B2 (en) * | 2007-01-29 | 2014-07-15 | Chyna, LLC | Use of ferritin to treat iron disorders |
| US8071542B2 (en) * | 2007-01-29 | 2011-12-06 | Chyna, LLC | Use of ferritin to treat iron deficiency disorders |
| AU2008353469B2 (en) * | 2008-03-28 | 2014-12-11 | Chyna Llc | Use of ferritin to treat iron deficiency disorders |
-
2011
- 2011-05-24 US US13/114,429 patent/US8778878B2/en active Active
-
2012
- 2012-05-24 CA CA2874042A patent/CA2874042C/en active Active
- 2012-05-24 DK DK12727897.6T patent/DK2714888T3/da active
- 2012-05-24 PL PL12727897T patent/PL2714888T3/pl unknown
- 2012-05-24 EP EP12727897.6A patent/EP2714888B1/en active Active
- 2012-05-24 CN CN201280024378.4A patent/CN103635570A/zh active Pending
- 2012-05-24 AU AU2012260682A patent/AU2012260682B2/en active Active
- 2012-05-24 WO PCT/GB2012/000461 patent/WO2012160333A2/en active Application Filing
- 2012-05-24 NO NO12727897A patent/NO2714888T3/no unknown
- 2012-05-24 JP JP2014511946A patent/JP2014516535A/ja active Pending
- 2012-05-24 BR BR112013029769-7A patent/BR112013029769B1/pt active IP Right Grant
- 2012-05-24 ES ES12727897.6T patent/ES2659185T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012260682B2 (en) | 2015-07-30 |
| CA2874042C (en) | 2020-10-06 |
| BR112013029769A2 (pt) | 2017-06-06 |
| PL2714888T3 (pl) | 2018-06-29 |
| WO2012160333A2 (en) | 2012-11-29 |
| JP2014516535A (ja) | 2014-07-17 |
| US8778878B2 (en) | 2014-07-15 |
| US20110287033A1 (en) | 2011-11-24 |
| EP2714888A2 (en) | 2014-04-09 |
| EP2714888B1 (en) | 2017-10-25 |
| AU2012260682A1 (en) | 2013-05-02 |
| CA2874042A1 (en) | 2012-11-29 |
| BR112013029769B1 (pt) | 2021-09-28 |
| CN103635570A (zh) | 2014-03-12 |
| ES2659185T3 (es) | 2018-03-14 |
| WO2012160333A3 (en) | 2013-03-07 |
| DK2714888T3 (da) | 2018-01-29 |